Grupo Pedro Jaén

Madrid 28006

0 studies enrolling now · 2 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Eczema

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling